Atlantic Urology Medical Group
Long Beach, California 90806-2766
0 studies enrolling now · 12 studies all time
What they study most
Benign Prostatic Hyperplasia, Cystitis, Interstitial, Invasive Extraintestinal Pathogenic Escherichia Coli Disease (IED) Prevention, Nocturia, Overactive Bladder, Prostate Adenocarcinoma, Prostate Cancer, Urinary Incontinence
Studies at this site
- A Study of Vaccination With 9-valent Extraintestinal Pathogenic Escherichia Coli Vaccine (ExPEC9V) in the Prevention of Invasive Extraintestinal Pathogenic Escherichia Coli Disease in Adults Aged 60 Years And Older With a History of Urinary Tract Infection in the Past 2 Years — Completed
- A Comparison of TULSA Procedure vs. Radical Prostatectomy in Participants With Localized Prostate Cancer — Running, not enrolling
- Dysport® Treatment of Urinary Incontinence in Adults Subjects With Neurogenic Detrusor Overactivity (NDO) Due to Spinal Cord Injury or Multiple Sclerosis - Study 1 — Stopped early
- A Study To Investigate Tanezumab In Patients With Interstitial Cystitis/ Painful Bladder Syndrome — Stopped early
- PROSTVAC®-VF/TRICOM™ Vaccine for the Treatment of Metastatic Prostate Cancer After Failing Hormone Therapy — Completed
- A Study of Degarelix in Patients With Prostate Cancer — Completed
- Efficacy and Safety of Desmopressin Melt for the Treatment of Nocturia — Completed
- Study Evaluating the Safety, Tolerability, and Efficacy of Dexmecamylamine (TC-5214) for Treatment of Overactive Bladder — Completed
- A Trial of Degarelix in Patients With Prostate Cancer — Completed
- R-Flurbiprofen in Treating Patients With Localized Prostate Cancer at Risk of Recurrence — Status unconfirmed
- Study of PRX302 for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia (BPH) — Completed
- Using Behavioral Therapy in Combination With Darifenacin for Symptoms of Overactive Bladder — Completed